Technology
Health
Biotechnology

Sierra Oncology

$1.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.73%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SRRA and other stocks, options, ETFs, and crypto commission-free!

About

Sierra Oncology, Inc. Common Stock, also called Sierra Oncology, is a clinical stage drug development company of therapeutics for the treatment of patients with cancer. Read More It engages in the business of researching, developing, and commercializing therapies for the treatment of patients with cancer. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

Employees
79
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
102.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
440.87K
High Today
$1.40
Low Today
$1.35
Open Price
$1.39
Volume
152.88K
52 Week High
$3.70
52 Week Low
$1.05

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
Therapy
2015 IPO
Canada

News

Yahoo FinanceMay 8

Sierra Oncology Reports First Quarter 2019 Results

Momelotinib regulatory pathway clarity anticipated in Q2 2019 - - SRA737 Phase 1/2 preliminary clinical data anticipated at the 2019 ASCO Annual Meeting - VANCOUVER , May 8, 2019 /CNW/ - Sierra Oncology, Inc. ("Sierra Oncology") (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with unmet needs in hematology and oncology, today reported its financial and operational results for the first quarter ended March 31, 2019 . "During the fi...

203
PR NewswireMay 6

Sierra Oncology to Attend Two Investor Conferences in May

VANCOUVER, May 6, 2019 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with significant unmet needs in hematology and oncology, today announced that members of its senior management team will be attending the SunTrust Robinson Humphrey 5th Annual Life Sciences Conference in New York on May 8th, and the Oppenheimer Oncology Insight Summit in New York on May 16th. Sun Trust Robinson Humphrey 5th An...

72
Yahoo FinanceApr 26

Imagine Owning Sierra Oncology (NASDAQ:SRRA) And Trying To Stomach The 72% Share Price Drop

386

Earnings

-$0.22
-$0.20
-$0.18
-$0.16
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.